Devan Bloch News Today

People who gained immunity -; either through vaccination or exposure -; against the original strain of SARS-CoV-2, the virus that causes COVID-19, also are likely to have some protection against the pathogen's omicron variant.

A prospective study by Johns Hopkins Medicine researchers demonstrates that convalescent plasma (shown here) – a blood product collected from patients

Nationwide, multicenter clinical trial led by Johns Hopkins shows convalescent plasma works as an early treatment for COVID-19, reducing need for hospitalization by 50%

Researchers at Johns Hopkins Medicine and Johns Hopkins Bloomberg School of Public Health put convalescent plasma to the test in June 2020 to see if it could help keep COVID patients out of the hospital.

A physician removes a bag of donated COVID-19 convalescent plasma after thawing. A study led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg

Although research to date has yielded conflicting results, Johns Hopkins investigators say their study is "definitive" in showing a benefit to convalescent plasma as a COVID-19 treatment.

As a new youth organization, only recently restarting in Sydney, BBYO NSW is moving in the right direction and becoming an “up and coming” youth organisation in Sydney.